Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 38 of Dermata Therapeutics, Inc.'s SEC filings and found 25 warrant series, 1 ATM program, 9 shelf registrations and 4 completed offerings on file for DRMA. The latest dilution event on file is a registration statement on Oct 20, 2026. Analysis updated Oct 29, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
APVOAptevo Therapeutics Inc.
LIMNLiminatus Pharma, Inc. Class A Common Stock
PMCBPharmaCyte Biotech, Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
ERNAErnexa Therapeutics Inc.
GRIGRI Bio, Inc.
KALAKALA BIO, Inc.
JUNSJupiter Neurosciences, Inc.
CMNDClearmind Medicine Inc.
SXTP60 Degrees Pharmaceuticals, Inc.
HLSQTessera Defense and Homeland Security Inc
APUSApimeds Pharmaceuticals US, Inc
MDCXMedicus Pharma Ltd. Common Stock
REVBRevelation Biosciences, Inc.
AIMDAinos, Inc.